STONEPINE CAPITAL, L.P. 4
4 · NOVELION THERAPEUTICS INC. · Filed Oct 16, 2019
Insider Transaction Report
Form 4
STONEPINE CAPITAL, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2019-10-11$0.65/sh+100,000$64,900→ 3,803,420 total
4 · NOVELION THERAPEUTICS INC. · Filed Oct 16, 2019
Common Stock